Bringing the fundamentals into focus…
Back to IDEXX Laboratories, Inc.
How IDEXX Laboratories, Inc. stacks up
IDXX · against 588 other Healthcare companies listed in US-listed
Valuation
49/ 100
Above the middle of the pack.
Ranked #189 of 589 · scores higher than 68% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 40–49, including IDXX · Click a bar to see the companies
Why valuation scores 49?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 3.0% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.2% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 63% of peers. Free cash flow yield: 2.4% vs peer median 0.0%
Metric by metric
Position: dot = IDXX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IDXX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 2.1% | -4.3% | 73% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 3.0% | -0.8% | 62% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 2.3% | -2.3% | 67% | 20% | |
| Book yieldHigher is better · 587 reported | 3.0% | 25.9% | 14% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around IDXX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 183 | 6.3B USD | 50 | 78 | |
| 183 | 126.5B USD | 50 | 56 | |
| 183 | 38.4B USD | 50 | 50 | |
| 189 | 4.0B USD | 49 | 46 | |
| 189 | 52.9B USD | 49 | 57 | |
| 189 | 1.0B USD | 49 | 74 | |
| 189 | 10.8B USD | 49 | 35 | |
| 193 | 505.4B USD | 48 | 53 | |
| 193 | 7.2B USD | 48 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score